Fuji Pharma Co., Ltd. (4554.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1658
First IPO Date
February 22, 2010
| Name | Title | Pay | Year Born |
| Shuhei Morita | President, Chief Executive Officer & Director | 0 | 1974 |
| Masayuki Naganawa | Managing Executive Officer & Head of Research and Development | 0 | N/A |
| Atsuya Mitsuhashi | Managing Executive Officer & Corporate Planning Department | 0 | 1971 |
| Hitoshi Yokoyama | Executive Officer & Head of Pharmaceutical Business Division | 0 | N/A |
| Satoshi Suzuki | Executive Vice President, Head of Business Strategy Division & Director | 0 | 1963 |
| Toyoyuki Kamide | Executive VP, Head of Corporate Management & Director | 0 | 1965 |
Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.